Salivary α-Amylase as a Metabolic Biomarker: Analytical Tools, Challenges, and Clinical Perspectives
International Journal of Molecular Sciences · 30.07.2025 · 26 (15) · 7365
DOI: 10.3390/ijms26157365 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 30.07.2025. Verfasst von Gita Erta und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Physiology and Biochemistry, Riga Stradins University, LV-1007 Riga, Latvia. Hauptthemen laut MEDLINE: Biomarkers, Salivary alpha-Amylases, Saliva. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Salivary α-amylase, primarily encoded by the AMY1 gene, initiates the enzymatic digestion of dietary starch in the oral cavity and has recently emerged as a potential biomarker in metabolic research. Variability in salivary amylase activity (SAA), driven largely by copy number variation of AMY1, has been associated with postprandial glycemic responses, insulin secretion dynamics, and susceptibility to obesity. This review critically examines current analytical approaches for quantifying SAA, including enzymatic assays, colorimetric techniques, immunoassays, and emerging biosensor technologies. The methodological limitations related to sample handling, intra-individual variability, assay standardization, and specificity are highlighted in the context of metabolic and clinical studies. Furthermore, the review explores the physiological relevance of SAA in energy homeostasis and its associations with visceral adiposity and insulin resistance. We discuss the potential integration of SAA measurements into obesity risk stratification and personalized dietary interventions, particularly in individuals with altered starch metabolism. Finally, the review identifies key research gaps and future directions necessary to validate SAA as a reliable metabolic biomarker in clinical practice. Understanding the diagnostic and prognostic value of salivary amylase may offer new insights into the prevention and management of obesity and related metabolic disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Human Physiology and Biochemistry, Riga Stradins University, LV-1007 Riga, Latvia.
ORCID-Profile: Gita Erta, Gita Gersone, Peteris Tretjakovs
Zitieren
APA
Erta, G., Gersone, G., Jurka, A., & Tretjakovs, P. (2025). Salivary α-Amylase as a Metabolic Biomarker: Analytical Tools, Challenges, and Clinical Perspectives. International Journal of Molecular Sciences, 26(15), 7365. https://doi.org/10.3390/ijms26157365
Vancouver
Erta G, Gersone G, Jurka A, Tretjakovs P. Salivary α-Amylase as a Metabolic Biomarker: Analytical Tools, Challenges, and Clinical Perspectives. International Journal of Molecular Sciences. 2025;26(15):7365. doi:10.3390/ijms26157365
BibTeX
@article{Erta2025,
author = {Erta, Gita and Gersone, Gita and Jurka, Antra and Tretjakovs, Peteris},
title = {Salivary α-Amylase as a Metabolic Biomarker: Analytical Tools, Challenges, and Clinical Perspectives},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {15},
pages = {7365},
doi = {10.3390/ijms26157365}
}
EUVIMED